CRISPR Therapeutics
CRSP
CRSP
497 hedge funds and large institutions have $6.57B invested in CRISPR Therapeutics in 2021 Q2 according to their latest regulatory filings, with 111 funds opening new positions, 171 increasing their positions, 125 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
12% more funds holding
Funds holding: 442 → 497 (+55)
6.34% less ownership
Funds ownership: 56.99% → 50.65% (-6.3%)
11% less call options, than puts
Call options by funds: $509M | Put options by funds: $570M
Holders
497
Holding in Top 10
12
Calls
$509M
Puts
$570M
Top Buyers
| 1 | +$141M | |
| 2 | +$111M | |
| 3 | +$25.7M | |
| 4 |
DVF
Discovery Value Fund
Singapore
|
+$22.6M |
| 5 |
HCS
Himension Capital (Singapore)
Singapore
|
+$19.1M |
Top Sellers
| 1 | -$127M | |
| 2 | -$86M | |
| 3 | -$62.5M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$62.3M |
| 5 |
FP
Financial Perspectives
Minneapolis,
Minnesota
|
-$44.9M |